Leyuan Xu1, Diana Sharkey2, Lloyd G Cantley1. 1. Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; and leyuan.xu@yale.edu lloyd.cantley@yale.edu. 2. Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut.
Abstract
BACKGROUND: After bilateral kidney ischemia/reperfusion injury (IRI), monocytes infiltrate the kidney and differentiate into proinflammatory macrophages in response to the initial kidney damage, and then transition to a form that promotes kidney repair. In the setting of unilateral IRI (U-IRI), however, we have previously shown that macrophages persist beyond the time of repair and may promote fibrosis. METHODS: Macrophage homing/survival signals were determined at 14 days after injury in mice subjected to U-IRI and in vitro using coculture of macrophages and tubular cells. Mice genetically engineered to lack Ccr2 and wild-type mice were treated ±CCR2 antagonist RS102895 and subjected to U-IRI to quantify macrophage accumulation, kidney fibrosis, and inflammation 14 and 30 days after the injury. RESULTS: Failure to resolve tubular injury after U-IRI results in sustained expression of granulocyte-macrophage colony-stimulating factor by renal tubular cells, which directly stimulates expression of monocyte chemoattractant protein-1 (Mcp-1) by macrophages. Analysis of CD45+ immune cells isolated from wild-type kidneys 14 days after U-IRI reveals high-level expression of the MCP-1 receptor Ccr2. In mice lacking Ccr2 and wild-type mice treated with RS102895, the numbers of macrophages, dendritic cells, and T cell decreased following U-IRI, as did the expression of profibrotic growth factors and proimflammatory cytokines. This results in a reduction in extracellular matrix and kidney injury markers. CONCLUSIONS: GM-CSF-induced MCP-1/CCR2 signaling plays an important role in the cross-talk between injured tubular cells and infiltrating immune cells and myofibroblasts, and promotes sustained inflammation and tubular injury with progressive interstitial fibrosis in the late stages of U-IRI.
BACKGROUND: After bilateral kidney ischemia/reperfusion injury (IRI), monocytes infiltrate the kidney and differentiate into proinflammatory macrophages in response to the initial kidney damage, and then transition to a form that promotes kidney repair. In the setting of unilateral IRI (U-IRI), however, we have previously shown that macrophages persist beyond the time of repair and may promote fibrosis. METHODS: Macrophage homing/survival signals were determined at 14 days after injury in mice subjected to U-IRI and in vitro using coculture of macrophages and tubular cells. Mice genetically engineered to lack Ccr2 and wild-type mice were treated ±CCR2 antagonist RS102895 and subjected to U-IRI to quantify macrophage accumulation, kidney fibrosis, and inflammation 14 and 30 days after the injury. RESULTS: Failure to resolve tubular injury after U-IRI results in sustained expression of granulocyte-macrophage colony-stimulating factor by renal tubular cells, which directly stimulates expression of monocyte chemoattractant protein-1 (Mcp-1) by macrophages. Analysis of CD45+ immune cells isolated from wild-type kidneys 14 days after U-IRI reveals high-level expression of the MCP-1 receptor Ccr2. In mice lacking Ccr2 and wild-type mice treated with RS102895, the numbers of macrophages, dendritic cells, and T cell decreased following U-IRI, as did the expression of profibrotic growth factors and proimflammatory cytokines. This results in a reduction in extracellular matrix and kidney injury markers. CONCLUSIONS:GM-CSF-induced MCP-1/CCR2 signaling plays an important role in the cross-talk between injured tubular cells and infiltrating immune cells and myofibroblasts, and promotes sustained inflammation and tubular injury with progressive interstitial fibrosis in the late stages of U-IRI.
Authors: Alaa S Awad; Gilbert R Kinsey; Konstantine Khutsishvili; Ting Gao; W Kline Bolton; Mark D Okusa Journal: Am J Physiol Renal Physiol Date: 2011-08-31
Authors: Fabio Jimenez; Marlon P Quinones; Hernan G Martinez; Carlos A Estrada; Kassandra Clark; Edgar Garavito; Jessica Ibarra; Peter C Melby; Seema S Ahuja Journal: J Immunol Date: 2010-04-19 Impact factor: 5.422
Authors: Piotr Czochra; Borut Klopcic; Erik Meyer; Johannes Herkel; Jose Francisco Garcia-Lazaro; Florian Thieringer; Peter Schirmacher; Stefan Biesterfeld; Peter R Galle; Ansgar W Lohse; Stephan Kanzler Journal: J Hepatol Date: 2006-05-30 Impact factor: 25.083
Authors: Sophia M Sears; Alexis A Vega; Zimple Kurlawala; Gabrielle B Oropilla; Austin Krueger; Parag P Shah; Mark A Doll; Robert Miller; Levi J Beverly; Leah J Siskind Journal: Kidney360 Date: 2022-02-10
Authors: Payel Sen; Alexandra Helmke; Chieh Ming Liao; Inga Sörensen-Zender; Song Rong; Jan-Hinrich Bräsen; Anette Melk; Hermann Haller; Sibylle von Vietinghoff; Roland Schmitt Journal: J Am Soc Nephrol Date: 2020-03-24 Impact factor: 10.121
Authors: Bryan R Conway; Eoin D O'Sullivan; Carolynn Cairns; James O'Sullivan; Daniel J Simpson; Angela Salzano; Katie Connor; Peng Ding; Duncan Humphries; Kevin Stewart; Oliver Teenan; Riinu Pius; Neil C Henderson; Cécile Bénézech; Prakash Ramachandran; David Ferenbach; Jeremy Hughes; Tamir Chandra; Laura Denby Journal: J Am Soc Nephrol Date: 2020-09-25 Impact factor: 10.121